152 related articles for article (PubMed ID: 34351481)
1. Supporting 'Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer'.
Iqbal MS; Kovarik J; Patil R; Kelly C
J Cancer Res Clin Oncol; 2022 Feb; 148(2):527-528. PubMed ID: 34351481
[No Abstract] [Full Text] [Related]
2. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
[TBL] [Abstract][Full Text] [Related]
3. Oligometastatic head and neck cancer: Comprehensive review.
Vengaloor Thomas T; Packianathan S; Bhanat E; Albert A; Abraham A; Gordy X; Kanakamedala M; Mehta D; Vijayakumar S
Head Neck; 2020 Aug; 42(8):2194-2201. PubMed ID: 32220043
[TBL] [Abstract][Full Text] [Related]
4. Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer".
Franzese C; Teriaca A; De Virgilio A; Mercante G; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2022 Apr; 148(4):1003-1004. PubMed ID: 34529130
[TBL] [Abstract][Full Text] [Related]
5. Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.
Tonneau M; Nebbache R; Larnaudie A; Thureau S; Pointreau Y; Blanchard P; Thariat J
Cancer Radiother; 2024 Feb; 28(1):83-92. PubMed ID: 37620212
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck.
Al-Assaf H; Erler D; Karam I; Lee JW; Higgins K; Enepekides D; Zhang L; Eskander A; Poon I
Head Neck; 2020 Aug; 42(8):2050-2057. PubMed ID: 32199031
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: When less is enough.
Swain M; Ghosh-Laskar S
Oral Oncol; 2021 May; 116():105265. PubMed ID: 33770592
[TBL] [Abstract][Full Text] [Related]
8. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
Turchan WT; Chmura SJ
Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
Kim MS; Malik NH; Chen H; Poon I; Husain Z; Eskander A; Boldt G; Louie AV; Karam I
Head Neck; 2022 Mar; 44(3):770-782. PubMed ID: 34927313
[TBL] [Abstract][Full Text] [Related]
11. Oligometastasis in Head and Neck Squamous Cell Carcinoma.
Moon DH; Sher DJ
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):803-811. PubMed ID: 35798219
[TBL] [Abstract][Full Text] [Related]
12. Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions.
Mahadevan A; Bucholz R; Gaya AM; Kresl JJ; Mantz C; Minnich DJ; Muacevic A; Medbery C; Yang J; Caglar HB; Davis JN
Future Oncol; 2014 Dec; 10(15):2307-10. PubMed ID: 25525840
[TBL] [Abstract][Full Text] [Related]
13. A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic disease in the context of new consensus definitions.
Li GJ; Arifin AJ; Al-Shafa F; Cheung P; Rodrigues GB; Palma DA; Louie AV
Ann Palliat Med; 2021 May; 10(5):6045-6051. PubMed ID: 32787370
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Chen H; Louie AV; Higginson DS; Palma DA; Colaco R; Sahgal A
Clin Oncol (R Coll Radiol); 2020 Nov; 32(11):713-727. PubMed ID: 32718762
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for head and neck cancer: an addition to the armamentarium against head and neck cancer.
Karam I; Poon I; Lee J; Liu S; Higgins K; Enepekides D; Sahgal A; Lo SS
Future Oncol; 2015; 11(21):2937-47. PubMed ID: 26414213
[TBL] [Abstract][Full Text] [Related]
16. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiotherapy in oligometastatic cancer.
Kennedy TAC; Corkum MT; Louie AV
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
[TBL] [Abstract][Full Text] [Related]
18. Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.
Connor MJ; Smith A; Miah S; Shah TT; Winkler M; Khoo V; Ahmed HU
Eur Urol Oncol; 2020 Oct; 3(5):582-593. PubMed ID: 32891600
[TBL] [Abstract][Full Text] [Related]
19. Emerging applications of stereotactic radiotherapy in head and neck cancer.
Truong MT; Grillone G; Tschoe C; Chin L; Kachnic LA; Jalisi S
Neurosurg Focus; 2009 Dec; 27(6):E11. PubMed ID: 19951054
[TBL] [Abstract][Full Text] [Related]
20. Treatment paradigms for oligometastatic pediatric cancers: a narrative review with a focus on radiotherapy approaches.
Smile TD; Parsai S; Pflederer TM; Murphy ES
Ann Palliat Med; 2021 May; 10(5):6002-6015. PubMed ID: 33183056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
